¼¼°èÀÇ BNP ¹× NT-proBNP ½ÃÀå ±Ô¸ð : ¿ëµµº°, °Ë»ç Àå¼Òº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global BNP And NTproBNP Market Size study, by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Others), by Location of Testing (Point of Care Testing, Laboratory Testing) and Regional Forecasts 2022-2032
»óǰÄÚµå : 1510222
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,024,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,869,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è BNP ¹× NT-proBNP ½ÃÀå ±Ô¸ð´Â 2023³â ¾à 12¾ï 5,320¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2024-2032³â 12.20% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. BNP(BÇü ³ªÆ®·ý ÀÌ´¢ ÆéŸÀ̵å)¿Í NT-proBNP(BNPÀÇ N¸»´Ü ÇÁ·ÎÈ£¸£¸ó)´Â ½ÉºÎÀü Áø´Ü¿¡ »ç¿ëµÇ´Â ¹ÙÀÌ¿À¸¶Ä¿ÀÔ´Ï´Ù.

BNP´Â ½ÉÀåÀÇ ½É½Ç¿¡¼­ ¾Ð·Â°ú ºÎÇÇ °úºÎÇÏ¿¡ ¹ÝÀÀÇÏ¿© »ý¼ºµÇ´Â È£¸£¸óÀ̸ç, NT-proBNP(N ¸»´Ü ÇÁ·Î b Çü ³ªÆ®·ý ÀÌ´¢ ÆéƼµå)´Â BNP(B Çü ³ªÆ®·ý ÀÌ´¢ ÆéƼµå)ÀÇ Àü±¸Ã¼À̸ç, µÑ ´Ù ½É½ÇÀÇ ºÎÇÇ ÆØÃ¢°ú ¾Ð·Â ºÎÇÏ¿¡ ¹ÝÀÀÇÏ¿© ½ÉÀå¿¡¼­ ¹æÃâµË´Ï´Ù. proBNP´Â BNP¿Í µ¿ÀÏÇÑ Àü±¸Ã¼ ºÐÀڷκÎÅÍ Àý´ÜµÈ °ÍÀ¸·Î, ¾ÈÁ¤¼º°ú ¼øÈ¯ ¹Ý°¨±â°¡ ±æ¾î ½ÉºÎÀü Áø´Ü ¹× °ü¸®¸¦ À§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, BNP¿Í NT-proBNPÀÇ ¼öÄ¡´Â ÀÓ»ó¿¡¼­ ½ÉºÎÀü ÁßÁõµµ Æò°¡, Ä¡·á Áöħ ¹× ȯÀÚ ¿¹ÈÄ ¿¹Ãø¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃøÁ¤Àº ½ÉºÎÀü ȯÀÚ¸¦ È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¼¼°è BNP ¹× NT-proBNP ½ÃÀåÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ½ÉºÎÀü Á¶±â Áø´Ü ¹× °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áø´Ü ±â¼úÀÇ ¹ßÀü°ú ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀåÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

BNP ¹× NT-proBNP ½ÃÀåÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Á¶±â Áø´Ü ¹× È¿°úÀûÀÎ ½ÉºÎÀü °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áø´Ü ±â¼úÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ °Ë»çÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÄÑ ÀÓ»ó ÇöÀå¿¡¼­ÀÇ Ã¤ÅÃÀ» È®´ëÇÒ °ÍÀÔ´Ï´Ù. ½ÉÀå Áúȯ¿¡ Ãë¾àÇÑ ¼¼°è Àα¸ÀÇ °í·ÉÈ­´Â ½ÃÀå ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶ó È®Ãæ, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ß°ú Á¶±â °³ÀÔÀÇ Á߿伺¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ·áÁøÀÇ ÀνÄÀÌ ³ô¾ÆÁø °Íµµ ½ÃÀå ¼ºÀå¿¡ ÈûÀ» º¸Å°í ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß ³ë·ÂÀÇ °á°ú·Î Çõ½ÅÀûÀÎ Á¦Ç° ¹× Áø´Ü ´É·ÂÀÇ Çâ»óÀ¸·Î ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï±¹¿¡¼­´Â ³·Àº ÀÎÁöµµ¿Í Á¦ÇÑµÈ Ã·´Ü ÀÇ·á ½Ã¼³·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »óȯ ¹®Á¦¿Í ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Çµµ ½ÃÀå È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¼¼°è BNP ¹× NT-proBNP ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀ¸·Î, 2023³â ºÏ¹Ì°¡ ¼öÀÍ Ãø¸é¿¡¼­ ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ºÏ¹Ì BNP ¹× NT-proBNP ½ÃÀåÀº ÷´Ü Áø´Ü ±â¼úÀÇ º¸±ÞÀ» ÃËÁøÇϴ ÷´Ü ÀÇ·á ÀÎÇÁ¶ó°¡ Ư¡ÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·üÀÌ ³ôÀ¸¸ç È¿°úÀûÀÎ °ü¸®¸¦ À§ÇØ Á¶±â¿¡ Á¤È®ÇÑ Áø´ÜÀÌ ÇÊ¿äÇÕ´Ï´Ù. ºÏ¹ÌÀÇ ¸·´ëÇÑ ÀÇ·áºñ ÁöÃâÀº °í±Þ Áø´Ü °Ë»ç ¹× Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, °­·ÂÇÑ R&D Ȱµ¿Àº Áø´Ü µµ±¸ÀÇ Áö¼ÓÀûÀÎ Çõ½Å°ú °³¼±¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ß ¹× Á¶±â °³ÀÔÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ·á Á¦°øÀÚ¿Í È¯ÀÚÀÇ ÀνÄÀÌ È®»êµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ Áö¿ø Á¤Ã¥ ¹× »óȯ ÇÁ·¹ÀÓ¿öÅ©µµ ÀÌ Áö¿ªÀÇ ½ÃÀå Áö¹è·Â¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº BNP ¹× NT-proBNP ¼¼°è ½ÃÀå¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ BNP ¹× NT-proBNP ½ÃÀå Á¤ÀÇ¿Í Á¶»ç °¡Á¤

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ BNP ¹× NT-proBNP ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ BNP ¹× NT-proBNP ½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå BNP ¹× NT-proBNP ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°(2022-2032³â)

Á¦6Àå BNP ¹× NT-proBNP ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : °Ë»ç Àå¼Òº°(2022-2032³â)

Á¦7Àå BNP ¹× NT-proBNP ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022-2032³â)

Á¦8Àå °æÀï Á¤º¸

Á¦9Àå Á¶»ç °úÁ¤

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global BNP And NTproBNP Market is valued at approximately USD 1253.2 million in 2023 and is anticipated to grow with a healthy growth rate of more than 12.20% over the forecast period 2024-2032. BNP (B-type Natriuretic Peptide) and NT-proBNP (N-terminal prohormone of BNP) are biomarkers used to diagnose heart failure. BNP is a hormone produced by the heart's ventricles in response to increased pressure and volume overload. NT-proBNP (N-terminal pro b-type Natriuretic Peptide) is a precursor to BNP (B-type Natriuretic Peptide), both of which are released by the heart in response to ventricular volume expansion and pressure overload. NT-proBNP is cleaved from the same precursor molecule as BNP and is used as a biomarker for diagnosing and managing heart failure due to its stability and longer half-life in circulation. Both BNP and NT-proBNP levels are used in clinical settings to assess the severity of heart failure, guide treatment, and predict patient outcomes. Their measurement is crucial for managing heart failure patients effectively. The Global BNP and NT-proBNP Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and increasing awareness about early diagnosis and management of heart failure. Advances in diagnostic technologies and a growing elderly population are drifting demand. Additionally, increasing healthcare expenditures and expanding healthcare infrastructure in emerging markets are further propelling market expansion.

The BNP And NTproBNP market are propelled by the rising prevalence of cardiovascular diseases and the increasing demand for early diagnosis and effective heart failure management. Advances in diagnostic technology enhance the accuracy and efficiency of these tests, leading to greater adoption in clinical settings. The aging global population, which is more susceptible to heart conditions, further drives market demand. Additionally, rising healthcare expenditures and the expansion of healthcare infrastructure, particularly in emerging markets, contribute to market growth. Increased awareness among patients and healthcare providers about the importance of early detection and intervention also supports the market. Continuous research and development efforts result in innovative products and improved diagnostic capabilities, further boosting the market. However, lack of awareness and limited availability of advanced healthcare facilities in developing countries hinder market growth. Reimbursement issues and stringent regulatory requirements also pose challenges to market expansion.

The key regions considered for the Global BNP And NTproBNP Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominates the market in terms of revenue. The BNP And NTproBNP market in North America is characterized by its advanced healthcare infrastructure, which facilitates the widespread adoption of sophisticated diagnostic technologies. The region has a high prevalence of cardiovascular diseases, necessitating early and accurate diagnosis for effective management. Substantial healthcare spending in North America ensures access to advanced diagnostic tests and treatments. Additionally, strong research and development activities contribute to continuous innovation and improvement in diagnostic tools. Widespread awareness among healthcare providers and patients about the importance of early detection and intervention further drives market growth. Supportive government policies and reimbursement frameworks also play a crucial role in the market's dominance in this region. The Asia-Pacific region is the fastest-growing market for BNP And NTproBNP globally.

Major market player included in this report are:

The detailed segments and sub-segment of the market are explained below:

By Application

By Location of Testing

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global BNP And NTproBNP Market Definition and Research Assumptions

Chapter 2. Executive Summary

Chapter 3. Global BNP And NTproBNP Market Dynamics

Chapter 4. Global BNP And NTproBNP Market Industry Analysis

Chapter 5. Global BNP And NTproBNP Market Size & Forecasts by Application 2022-2032

Chapter 6. Global BNP And NTproBNP Market Size & Forecasts by Location of Testing 2022-2032

Chapter 7. Global BNP And NTproBNP Market Size & Forecasts by Region 2022-2032

Chapter 8. Competitive Intelligence

Chapter 9. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â